Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study

Detalles Bibliográficos
Autores principales: Hannawi, Suad, Zhang, Rong‐Rong, Abuquta, Alaa, Safeldin, Linda, Hassan, Aala, Alamadi, Ahmad, Hossain, Tasmiah, Mostafa, Mohamed, Ghoneim, Yasser, Solo, Jennifer, Zheng, Hong‐Xia, Wu, Ding‐Feng, Yu, Dan‐Dan, Yuan, Jia‐Cheng, Zhao, Di, Lin, Rui, Ying, Bo, Qin, Cheng‐Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Journal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447877/
https://www.ncbi.nlm.nih.gov/pubmed/37612802
http://dx.doi.org/10.1002/ctm2.1387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447877/
https://www.ncbi.nlm.nih.gov/pubmed/37612802
http://dx.doi.org/10.1002/ctm2.1387

Ejemplares similares